Beta cells exhibit changes in chromatin activity in T2D a, Schematic of ...

Download scientific diagram | Beta cells exhibit changes in chromatin activity in T2D a , Schematic of the study design. snATAC-seq was performed on nuclei from pancreatic islets from 11 ...

Here we integrate information from measurements of chromatin activity , gene expression and function in single beta cells with genetic association data to identify disease-causal gene regulatory changes in T2D .
Epigenetics in

Among the variants tested for enhancer activity using luciferase reporter assays in MIN6 β- cells , more than half exhibited consistent effects with in vivo chromatin accessibility changes in human islets.
Beta cell cCREs with binding sites for differential TFs in both beta-1 and beta-2 cells are shown. Differentially expressed genes in T2D beta cells are indicated by gray shaded boxes.

Functional interrogation of twenty type 2 diabetes ...
Knockout of T2D genes results in large-scale transcriptomic and chromatin accessibility changes To profile the transcriptomic and chromatin accessibility changes of each KO compared with WT, we purified INS -GFP + hESC-β cells derived from one KO clone for each T2D gene along with the two WT lines and performed RNA sequencing (RNA-seq) as well ...
In T2D beta cells , but not alpha cells , we observed further demethylation compared to healthy controls, underscoring a unique capacity of beta cells to respond to changes in metabolic demand.

Integrating genetics with single
Both beta cell subtypes exhibit activation of a stress-response transcriptional program and functional impairment in T2D , which is probably induced by the T2D -associated metabolic environment.
Together, our findings define BAF60a as a key epigenetic checkpoint factor that integrates metabolic signals to remodel the chromatin landscape and coordinate transcriptional programs controlling β cell function in T2D .

Single cell multiomic analysis reveals diabetes
Here, we integrate single- cell transcriptome, single-nuclei chromatin accessibility, and cell -type specific 3D genome profiles from human islets and identify Type II Diabetes (T2D)-associated β- cell heterogeneity at both transcriptomic and epigenomic levels.







The traditional classification of the disorder as either type 1 (T1D) (β- cell autoimmunity-mediated) or type 2 ( T2D ) (insulin resistance and β- cell dysfunction-mediated) belies a more heterogeneous pathophysiology that, in some individuals, exhibit features of more than one type.